There were 1,650 press releases posted in the last 24 hours and 401,759 in the last 365 days.

Preliminary Agenda Announced for the Upcoming Molecular Medicine Tri-Conference

Over 3000 life science and drug discovery professionals will be present in San Francisco

NEEDHAM, MA , USA, August 20, 2014 /EINPresswire.com/ -- Cambridge Healthtech Institute announces the preliminary agenda for the 22nd International Molecular Medicine Tri-Conference, which is taking place February 15-20, 2015 at Moscone North Convention Center in San Francisco.

The Tri-Conference is the industry's Preeminent Event on Molecular Medicine, focusing on Drug Discovery, Genomics, Diagnostics and Information Technology. Spanning six days this year, the Tri-Conference includes an expanded program that includes 6 symposia, over 20 short courses, and 17 conference programs.

This year’s expanded agenda includes conference programs including: Molecular Diagnostics, Personalized Diagnostics, Cancer Molecular Markers, Circulating Tumor Cells, Digital Pathology, Companion Diagnostics, PCR for Molecular Medicine, Genomic Sample Prep and Biospecimen Science, Epigenomics in Disease, Genome and Transcriptome Analysis, Translational to Clinical R&D, Clinical Sequencing, Genomic Technologies for Patient Stratification, Predictive Preclinical Models in Oncology, Technology-Driven Oncology Clinical Development, Bioinformatics for Big Data and Integrated Pharma Informatics & Data Science.

The 2015 conference symposia programs include: New Frontiers in Gene Editing, Point-of-Care Diagnostics, Genomics in Medicine, Clinical Cancer Immunotherapy, Circulating Cell-Free DNA and Genomics & Sequencing Data Integration, Analysis and Visualization.

The newest programs added to the Tri-Conference agenda are Genomic Technologies for Patient Stratification, Technology-Driven Oncology Clinical Development, New Frontiers in Gene Editing and Clinical Cancer Immunotherapy.

A full program agenda and registration information can be accessed online at http://www.Tri-Conference.com

About Cambridge Healthtech Institute (http://www.chicorporate.com)
Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners Cambridge Healthtech Media Group and Knowledge Foundation.

Lisa Scimemi
Cambridge Healthtech Institute
781.972.5400
email us here